These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1157 related items for PubMed ID: 2957440

  • 1. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS, Sharrow SO, Shearer GM.
    J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440
    [Abstract] [Full Text] [Related]

  • 2. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M, Sharrow SO, Shearer GM.
    J Immunol; 1988 Apr 15; 140(8):2600-8. PubMed ID: 3258615
    [Abstract] [Full Text] [Related]

  • 3. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function.
    Moser M, Mizuochi T, Sharrow SO, Singer A, Shearer GM.
    J Immunol; 1987 Mar 01; 138(5):1355-62. PubMed ID: 2949013
    [Abstract] [Full Text] [Related]

  • 4. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M, Via CS, Shearer GM.
    J Immunol; 1988 Jul 15; 141(2):430-9. PubMed ID: 2968400
    [Abstract] [Full Text] [Related]

  • 5. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T, Munitz TI, McCarthy SA, Andrysiak PM, Kung J, Gress RE, Singer A.
    J Immunol; 1986 Nov 01; 137(9):2740-7. PubMed ID: 2944960
    [Abstract] [Full Text] [Related]

  • 6. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL, Charley MR, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Jan 01; 138(1):51-7. PubMed ID: 2946780
    [Abstract] [Full Text] [Related]

  • 7. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
    Parkman R.
    J Immunol; 1986 May 15; 136(10):3543-8. PubMed ID: 2871104
    [Abstract] [Full Text] [Related]

  • 8. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST, Radaszkiewicz T, Gleichmann E.
    J Immunol; 1984 Apr 15; 132(4):1669-78. PubMed ID: 6230390
    [Abstract] [Full Text] [Related]

  • 9. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G, Schurmans S, Berney M, Izui S, del Giudice G, Lambert PH.
    J Autoimmun; 1995 Apr 15; 8(2):177-92. PubMed ID: 7612147
    [Abstract] [Full Text] [Related]

  • 10. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Oct 01; 139(7):2137-42. PubMed ID: 3309052
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of the mechanism of graft-vs-host like disease in [lpr/lpr----+/+] chimera].
    Matsunaga T.
    Hokkaido Igaku Zasshi; 1987 Sep 01; 62(5):779-89. PubMed ID: 2961673
    [Abstract] [Full Text] [Related]

  • 12. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S, Azuma T, Shimizu J, Shima J, Kitagawa S, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Aug 01; 141(3):721-7. PubMed ID: 2456330
    [Abstract] [Full Text] [Related]

  • 13. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H, Mizuochi T, McCarthy SA, Cleveland CA, Singer A.
    J Immunol; 1987 Jan 01; 138(1):10-7. PubMed ID: 2946773
    [Abstract] [Full Text] [Related]

  • 14. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U, Shearer GM.
    J Immunol; 1983 Apr 01; 130(4):1561-6. PubMed ID: 6220057
    [Abstract] [Full Text] [Related]

  • 15. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM, Radaszkiewicz T, Terraneo L, Gleichmann E.
    J Immunol; 1983 Jun 01; 130(6):2693-701. PubMed ID: 6602176
    [Abstract] [Full Text] [Related]

  • 16. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H.
    J Immunol; 1989 Sep 01; 143(5):1447-52. PubMed ID: 2527264
    [Abstract] [Full Text] [Related]

  • 17. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL, Fitch FW.
    J Immunol; 1988 Sep 15; 141(6):1808-12. PubMed ID: 2459190
    [Abstract] [Full Text] [Related]

  • 18. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T.
    J Immunol; 1986 Apr 01; 136(7):2715-9. PubMed ID: 3005417
    [Abstract] [Full Text] [Related]

  • 19. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K, Algara DS, Orbach-Arbouys S.
    J Immunol; 1987 Feb 15; 138(4):1038-41. PubMed ID: 3492538
    [Abstract] [Full Text] [Related]

  • 20. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL, Bryde SE, Lipsky PE.
    J Immunol; 1988 Nov 15; 141(10):3377-82. PubMed ID: 3053897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.